Current Members

Milton J. Henrichs Chair in Pharmaceutical Sciences, UW–Madison School of Pharmacy
Professor of Pharmaceutical Sciences, Carbone Cancer Center, and Biomedical Engineering
Director of Wisconsin Center for NanoBioSystems, UW–Madison School of Pharmacy

1999 BS in fiber and polymer engineering, Hanyang University, Seoul, Korea
2001 MS in polymer engineering, Hanyang University/Korea Inst. of Sci. and Technol. (KIST), Seoul, Korea
2006 PhD in macromolecular science and engineering, University of Michigan, Ann Arbor, Michigan
2008 Postdoc, chemical engineering, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts

Dr. Seungpyo Hong is the Milton J. Henrichs Chair in pharmaceutical sciences and professor of pharmaceutics in the Pharmaceutical Sciences Division, School of Pharmacy at the University of Wisconsin–Madison. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). He also serves as associate editor for Nanomedicine: Nanotechnology, Biology and Medicine of Elsevier. He graduated from Hanyang University in Seoul, South Korea with BS and MS degrees in polymer engineering in 1999 and 2001, respectively.

After working as a researcher at Korea Institute of Science and Technology (KIST), he started his PhD study at the University of Michigan working with his advisors Professors Mark Banaszak Holl and James Baker, Jr. Dr. Hong graduated with his PhD in macromolecular science and engineering in 2006 and joined Massachusetts Institute of Technology (MIT) as a postdoctoral associate in the laboratory of Professor Robert Langer.

From 2008 to 2014, Dr. Hong was an assistant professor in the College of Pharmacy at the University of Illinois at Chicago (UIC), where he was promoted to associate professor with tenure in 2014. He joined the UW–Madison faculty as full professor in 2016.

Since 2008, he has led a research group under the major research theme of “biomimetic nanotechnology” for cancer diagnosis and treatment. To date, Dr. Hong’s research has culminated in more than 120 peer-reviewed articles that have a combined total number of citations of approximately 20,000 with an h-index of 49, 1 co-edited book, eight book chapters, and more than 22 issued or pending patents. He has given more than 180 invited talks worldwide and attended more than 200 conference proceedings.

His academic and research achievements have been recognized by the scientific community, resulting in a number of awards, including 2012 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies and 2012 UIC Researcher of the Year—Rising Star Award. He was inducted as a Fellow to the American Institute for Medical and Biological Engineering (AIMBE) in 2022.

Experience

• 1999–2002 research assistant, Polymer Hybrids Research Center, KIST, Seoul, South Korea
• 2008–2014 assistant professor, College of Pharmacy, University of Illinois at Chicago
• 2014–2016 associate professor and director of graduate education for the College of Pharmacy, University of Illinois at Chicago
• 2015–2018 associate professor (with joint appointment), Underwood International College, Yonsei University, Seoul/Incheon, South Korea
• 2015–present co-founder and president, Capio Biosciences, Inc., Madison, Wisconsin
• 2016–present associate editor, Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier
• 2016–present professor, Pharmaceutical Sciences Division, University of Wisconsin–Madison
• 2017–present member, Carbone Comprehensive Cancer Center, University of Wisconsin–Madison
• 2018–present director, Wisconsin Center for NanoBioSystems, University of Wisconsin–Madison

See Dr. Hong’s School of Pharmacy profile.